We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$27.1B
AUM Growth
+$3.44B
Cap. Flow
+$921M
Cap. Flow %
3.4%
Top 10 Hldgs %
34.67%
Holding
1,351
New
69
Increased
716
Reduced
273
Closed
50

Top Sells

Rank Stock Value
1
OHI icon
Omega Healthcare
OHI
+$137M
2
AMT icon
American Tower
AMT
+$116M
3
PSA icon
Public Storage
PSA
+$97.9M
4
UDR icon
UDR
UDR
+$80.4M
5
AVB icon
AvalonBay Communities
AVB
+$73.9M

Sector Composition

Rank Sector Weight
1 Real Estate 30.73%
2 Technology 27.75%
3 Communication Services 10.3%
4 Consumer Discretionary 6.75%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBIO icon
1076
BridgeBio Pharma
BBIO
$16.8B
$29K ﹤0.01%
664
+40
+6% +$1.46K
BPMC
1077
DELISTED
Blueprint Medicines
BPMC
$29K ﹤0.01%
225
+15
+7% +$1.56K
UDMY
1078
DELISTED
Udemy
UDMY
$29K ﹤0.01%
4,180
-600
-13% -$4.14K
EWZ icon
1079
iShares MSCI Brazil ETF
EWZ
$9.13B
$28K ﹤0.01%
980
COHR icon
1080
Coherent
COHR
$47.6B
$27K ﹤0.01%
300
+100
+50% +$7.2K
ROIV icon
1081
Roivant Sciences
ROIV
$24.3B
$27K ﹤0.01%
2,402
-5,353
-69% -$58K
VRNA
1082
DELISTED
Verona Pharma
VRNA
$25K ﹤0.01%
269
JAZZ icon
1083
Jazz Pharmaceuticals
JAZZ
$16.1B
$23K ﹤0.01%
215
-1,785
-89% -$194K
MDGL icon
1084
Madrigal Pharmaceuticals
MDGL
$12.4B
$23K ﹤0.01%
77
+5
+7% +$1.49K
CPK icon
1085
Chesapeake Utilities
CPK
$3.31B
$21K ﹤0.01%
+171
New +$21.5K
GH icon
1086
Guardant Health
GH
$19B
$21K ﹤0.01%
408
AXSM icon
1087
Axsome Therapeutics
AXSM
$12.1B
$18K ﹤0.01%
177
+17
+11% +$1.8K
EWW icon
1088
iShares MSCI Mexico ETF
EWW
$1.92B
$18K ﹤0.01%
300
NUVL
1089
DELISTED
Nuvalent
NUVL
$18K ﹤0.01%
239
+22
+10% +$1.61K
VGSH icon
1090
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$18K ﹤0.01%
+298
New +$17.5K
ALKS icon
1091
Alkermes
ALKS
$8.42B
$17K ﹤0.01%
593
+59
+11% +$1.76K
ADMA icon
1092
ADMA Biologics
ADMA
$2.04B
$16K ﹤0.01%
858
+78
+10% +$1.59K
CIEN icon
1093
Ciena
CIEN
$49.6B
$16K ﹤0.01%
200
-200
-50% -$14.3K
AKRO
1094
DELISTED
Akero Therapeutics
AKRO
$15K ﹤0.01%
272
VWOB icon
1095
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.17B
$15K ﹤0.01%
228
+210
+1,167% +$13.4K
CYTK icon
1096
Cytokinetics
CYTK
$10.8B
$14K ﹤0.01%
429
+40
+10% +$1.39K
KRYS icon
1097
Krystal Biotech
KRYS
$10.7B
$14K ﹤0.01%
104
+9
+9% +$1.32K
RYTM icon
1098
Rhythm Pharmaceuticals
RYTM
$7.41B
$14K ﹤0.01%
229
+26
+13% +$1.59K
ACAD icon
1099
Acadia Pharmaceuticals
ACAD
$4.45B
$13K ﹤0.01%
602
+53
+10% +$985
ACLX
1100
DELISTED
Arcellx
ACLX
$13K ﹤0.01%
198
+20
+11% +$1.25K

Similar funds

Daiwa Securities Group's Q2 2025 Portfolio in Review

As of Q2 2025, Daiwa Securities Group held 1,351 positions worth $27.1B, up 15% from $23.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $921M of net new capital in Q2 2025, opening 69 new positions and adding to 716 existing holdings. Its largest new stake was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.

By sector, the portfolio is most concentrated in Real Estate at 31% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Omega Healthcare, an estimated $137M trimmed.

  • Daiwa Securities Group's largest Q2 2025 buy was SmartStop Self Storage REIT: 313,858 shares worth $11.4M.
  • Daiwa Securities Group added most to Apple in Q2 2025, an estimated $162M increase.
  • Daiwa Securities Group's biggest Q2 2025 reduction was Omega Healthcare, cutting an estimated $137M.
  • Daiwa Securities Group fully exited iShares Core US Aggregate Bond ETF in Q2 2025, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $27.1B portfolio in Q2 2025.
  • Daiwa Securities Group opened 69 new positions and closed 50 in Q2 2025.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $27.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2025, filed 14 Aug 2025.